| Autor: |
Shaimova VA; Academy of Postgraduate Education of the Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency, Moscow, Russia.; OOO Centr Zreniya, Chelyabinsk, Russia., Trubilin VN; A.I. Burnasyan Federal Medical Biophysical Center of the Federal Medical Biological Agency, Moscow, Russia., Shaimov TB; OOO Centr Zreniya, Chelyabinsk, Russia., Islamova GR; OOO Centr Zreniya, Chelyabinsk, Russia., Shaimov RB; OOO Centr Zreniya, Chelyabinsk, Russia., Kuchkildina SK; OOO Centr Zreniya, Chelyabinsk, Russia., Askaeva AA; OOO Centr Zreniya, Chelyabinsk, Russia., Fomin AV; AO Treidomed Invest, Moscow, Russia. |
| Abstrakt: |
The article presents a clinical case of subthreshold micropulse laser (SML) treatment of chronic central serous chorioretinopathy (CSC) in the left eye of a 44-year-old female patient K . with dye allergy. The patient first noticed a gray spot, distortion of objects in February, 2018. During 2018-2020 she suffered 5 relapses, repeated unsuccessful conservative treatment, and completed a course of antiangiogenic therapy in the form of three monthly intravitreal injections of ranibizumab. After experiencing stress on 11.08.20 she noted acute deterioration. Laser treatment was carried out on 20.09.20 with the Navilas 577s navigation system (wavelength 577 nm). After the power titration and calculation, the contact-free subthreshold micropulse laser treatment was carried out without anesthesia in three zones: 200 mW for fovea, 240 mW for parafovea and 340 mW for periphovea. Other settings: pulse duration - 200 ms, spot diameter - 100 µm, duty cycle - 5%. Total number of laser pulses - 1000. The retina reattached completely despite the patient having previously recovered from the coronavirus infection and the use of corticosteroids. |
